# Blood Serum From Obese Women Raises ROS Production by Neural Stem Cells

**Authors:** Phelipe Elias da Silva, Natássia Caroline Resende Corrêa, Natália Ferreira Silva, Carlos Ueira‐Vieira, Hebreia Oliveira Almeida‐Souza, Mario Machado Martins, Tiara da Costa Silva, Renata Graciele Zanon

PMC · DOI: 10.1002/dneu.70021 · Developmental Neurobiology · 2026-03-17

## TL;DR

Blood serum from obese women increases oxidative stress in neural stem cells, suggesting potential impacts on early brain development.

## Contribution

Demonstrates that serum from obese women induces higher reactive oxygen species in neural stem cells compared to non-obese serum.

## Key findings

- Exposure to serum from obese women increases ROS production in neural stem cells.
- Serum from both obese and non-obese women reduces NSC viability and alters stress-related markers.
- Obese serum induces a sustained ROS increase and transient metabolic changes in NSCs.

## Abstract

Maternal obesity has been associated with adverse pregnancy outcomes and altered fetal development, but the direct influence of circulating maternal factors on early human neural cells remains poorly understood. Neural stem cells (NSCs) provide a controlled system to examine how metabolic and inflammatory changes may affect early neurodevelopment. We differentiated human embryonic stem cells into NSCs and exposed them to 10% serum from non‐obese or obese women. Cell viability, oxidative stress, metabolic activity, proliferation, and neural marker expression were evaluated. Metabolomic profiling confirmed distinct serum signatures between donor groups, particularly involving lipid and redox‐related metabolites. Exposure to human serum, independent of donor phenotype, reduced viability, decreased Ki‐67 and PAX6 expression, increased Caspase‐3 and p53 labeling, and altered progenitor markers, indicating activation of stress pathways. Although overall responses to non‐obese and obese serum were similar, NSCs exposed to obese serum showed a sustained increase in ROS and a transient elevation in resazurin reduction at later time points. These differences were modest but statistically significant and may reflect altered metabolic and redox handling. Together, the findings show that serum exposure imposes considerable stress on NSCs in vitro and that obesity‐related factors may subtly amplify oxidative responses. The study also underscores the limitations of this artificial model and highlights the need for systems that more closely approximate physiological conditions during neurodevelopment.

## Linked entities

- **Genes:** Mki67 (antigen identified by monoclonal antibody Ki 67) [NCBI Gene 17345], PAX6 (paired box 6) [NCBI Gene 5080], Casp3 (caspase 3) [NCBI Gene 12367], TP53 (tumor protein p53) [NCBI Gene 7157]
- **Diseases:** obesity (MONDO:0011122)

## Full-text entities

- **Genes:** TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, FABP7 (fatty acid binding protein 7) [NCBI Gene 2173] {aka B-FABP, BLBP, FABPB, MRG}, RBFOX3 (RNA binding fox-1 homolog 3) [NCBI Gene 146713] {aka FOX-3, FOX3, HRNBP3, NEUN}, SOX1 (SRY-box transcription factor 1) [NCBI Gene 6656], TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, POU5F1 (POU class 5 homeobox 1) [NCBI Gene 5460] {aka OCT3, OCT4, OCT4Borf1, OTF-3, OTF3, OTF4}, H3P16 (H3 histone pseudogene 16) [NCBI Gene 644914] {aka H3.6, H3F3AP6, p21}, C3 (complement C3) [NCBI Gene 718] {aka AHUS5, ARMD9, ASP, C3a, C3b, CPAMD1}, BMP1 (bone morphogenetic protein 1) [NCBI Gene 649] {aka OI13, PCOLC, PCP, TLD}, CASP3 (caspase 3) [NCBI Gene 836] {aka CPP32, CPP32B, SCA-1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, SOX2 (SRY-box transcription factor 2) [NCBI Gene 6657] {aka ANOP3, MCOPS3}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, EGF (epidermal growth factor) [NCBI Gene 1950] {aka HOMG4, URG}, FOXG1 (forkhead box G1) [NCBI Gene 2290] {aka BF1, BF2, FHKL3, FKH2, FKHL1, FKHL2}, C5AR1 (complement C5a receptor 1) [NCBI Gene 728] {aka C5A, C5AR, C5R1, CD88}, NANOG (Nanog homeobox) [NCBI Gene 79923], PAX6 (paired box 6) [NCBI Gene 5080] {aka AN, AN1, AN2, ASGD5, D11S812E, FVH1}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, FGF2 (fibroblast growth factor 2) [NCBI Gene 2247] {aka BFGF, FGF-2, FGFB, HBGF-2}, CXCL11 (C-X-C motif chemokine ligand 11) [NCBI Gene 6373] {aka H174, I-TAC, IP-9, IP9, SCYB11, SCYB9B}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}
- **Diseases:** neurodevelopmental (MESH:D008607), developmental neurotoxicity (MESH:D020258), mitochondrial (MESH:D028361), neurodegenerative (MESH:D019636), infections (MESH:D007239), maternal obesity (MESH:D000079262), OB (MESH:D009765), NSC (OMIM:617394), hypertension (MESH:D006973), hypertrophy (MESH:D006984), infectious disorders (MESH:D003141), gestational diabetes (MESH:D016640), inflammation (MESH:D007249), metabolic (MESH:D008659), hypoxia (MESH:D000860), cancer (MESH:D009369), tissue (MESH:D017695)
- **Chemicals:** paraformaldehyde (MESH:C003043), PI (MESH:D011419), TRIzol (MESH:C411644), triglyceride (MESH:D014280), Resazurin (MESH:C005843), Texas Red (MESH:C034657), lipid (MESH:D008055), calcium (MESH:D002118), AM (MESH:D000576), Calcein (MESH:C007740), agarose (MESH:D012685), (3S,5R,6R)-3,5-dihydroxy-6,7-dihydro-12'-apo-beta-carotene-12'-al (-), Triton X-100 (MESH:D017830), fatty acids (MESH:D005227), ND (MESH:D009354), FADH2 (MESH:C058805), Superoxide (MESH:D013481), Pyocyanin (MESH:D011710), water (MESH:D014867), P (MESH:D010758), free fatty acids (MESH:D005230), formic acid (MESH:C030544), glucose (MESH:D005947), diterpenoids (MESH:D004224), Y-27632 (MESH:C108830), pentadecyl acetate (MESH:C541426), ROS (MESH:D017382), NADH (MESH:D009243), methanol (MESH:D000432), phospholipid (MESH:D010743), PBS (MESH:D007854), Diacylglycerol (MESH:D004075)
- **Species:** Homo sapiens (human, species) [taxon 9606], Cistus ladanifer (species) [taxon 335173]
- **Cell lines:** ESCs — Homo sapiens (Human), Embryonic stem cell (CVCL_UI95), S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232), BR-1 — Homo sapiens (Human), Embryonic stem cell (CVCL_C062), NSC — Mus musculus (Mouse), Hybrid cell line (CVCL_B6XY), hESCs — Homo sapiens (Human), Telomerase immortalized cell line (CVCL_C464)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12996446/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12996446/full.md

## References

161 references — full list in the complete paper: https://tomesphere.com/paper/PMC12996446/full.md

---
Source: https://tomesphere.com/paper/PMC12996446